A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
|
2019
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA, ASPR
|
NCI, NIAID
|
2013
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
|
|
Adolescent Human Immunodeficiency Virus (HIV) Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
2016
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing Protection and Care for Children in Adversity: A U.S. Government Strategy for International Assistance (APCCA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NICHD, NIMH
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2015
|
|
Advisory Committee on Immunization Practices (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
|
|
Advisory Committee on Maternal/Pediatric RSV Vaccines (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, HRSA, IHS, CMS
|
NIAID
|
2022
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA, OS
|
NIAID
|
2009
|
|
Advisory Committee on RSV Vaccines in Older Adults (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, CMS
|
|
2022
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
Agency Priority Goals Maternal Health
|
Committee, Advisory Group, or Work Group
|
HRSA, NIH, ASPE, CDC, CMS, FDA, OASH, ACF, OGA, AHRQ, ACL
|
OD/ DPCPSI/ ORWH, NICHD, OD/ IMOD, OD/ DPCPSI/ OEPR
|
2022
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS (AAP-COPA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Genetics (AAP-COG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Section on Obesity (AAP-SOO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics Council on Injury, Violence and Poison Prevention (AAP-COIVPP)
|
Committee, Advisory Group, or Work Group
|
ACF, HRSA, IHS
|
NICHD
|
2011
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Assay subgroup for SARS-CoV-2
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, BARDA, FDA
|
NIAID
|
2020
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Behavioral Health Coordinating Council (BHCC) Children and Youth Behavioral Health Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CMS, ACL, AHRQ, FDA, IHS, ASPE, CDC, OASH
|
NICHD, NIMH, NIDA
|
2021
|
|
Behavioral Health Coordinating Council (BHCC) Performance Measures, Data, and Evaluation Subcommittee (MDE)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIMH
|
2021
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NICHD
|
2009
|
|
Best Pharmaceuticals for Children Act (BPCA) Research Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Best Pharmaceuticals for Children Act (BPCA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NHLBI, NCI
|
|
|
Biodefense Coordination Team (BCT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
2019
|
|
Biodosimetry Trans-NIH Working Group and Special Journal Issue
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
|
2019
|
|
Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2011
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CC, NIAID7, NHLBI
|
2012
|
|
Board of Scientific Counselors (BSC) of the CDC National Center for Injury Prevention and Control
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIA, NICHD, NIDA, NIMH
|
2011
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
Botulism Guidelines Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2016
|
|
Brain Attack Coalition (BAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NINDS
|
1997
|
|
Brain Research through Advancing Innovative Neurotechnologies Initiative (BRAIN Initiative)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NEI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
Canadian - U.S. Dietary Reference Intakes Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI/ ODS
|
2005
|
|
Cancer Diagnostic Devices Interagency Task Force (CD2) - MOU among NCI, FDA, HRSA
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
|
2021
|
|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2018
|
|
Center for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) Opioids Work Group (OWG)
|
Committee, Advisory Group, or Work Group
|
CMS
|
NIDA, NCCIH, NINDS, NIMH
|
2018
|
|
Chemical Hazards Emergency Medical Management (CHEMM) Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC
|
NLM, NICHD
|
2010
|
|
Clinical Immunization Safety Assessment Network (CISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NHLBI
|
2021
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2013
|
|
CMS-NIH Leadership Council
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/ IMOD, OD/ OER, OD/ OSP
|
2011
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS
|
2018
|
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee (CARBx-JOC)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
NIAID
|
2016
|
|
Commissioned Corps of the U.S. Public Health Service (USPHS) Oral Health Coordinating Committee (OHCC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, OASH, IHS, SAMHSA
|
|
1990
|
|
Community Guide Cardiovascular Coordination Team
|
Committee, Advisory Group, or Work Group
|
CDC
|
NHLBI
|
2013
|
|
Community Preventive Services Task Force (CPSTF)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, AHRQ, OASH, HRSA, IHS, SAMHSA
|
OD/ DPCPSI
|
1996
|
|
Contract to fund Congressional mandated National Academies of Sciences, Engineering, and Medicine (NASEM) study on Organ Donation and Transplantation
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NHLBI, NIAID, NIDDK
|
2019
|
|
Countering Biothreats IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-IPC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIAID
|
2020
|
|
CTAC Ad hoc Strategic Planning Working Group (CTAC SPWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS
|
|
2019
|
|
CTAC ad hoc Working Group on Streamlining Clinical Trials (CTAC SCTWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2022
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDCD
|
2007
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2012
|
|
Department of Health and Human Services (DHHS) Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, OD/ DPCPSI/ OAR
|
1989
|
|
Department of Health and Human Services (DHHS) Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (DHHS) Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2005
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
|
1990
|
|
Department of Health and Human Services (DHHS) Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2008
|
|
Department of Health and Human Services (HHS) Biovigilance Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2009
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
1974
|
|
Dietary Supplement Research Coordination Committee (DSRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ONR
|
2022
|
|
Digestive Diseases Interagency Coordinating Committee (DDICC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NCI, NIBIB
|
1985
|
|
Drug Development Interest Group
|
Committee, Advisory Group, or Work Group
|
ASPR
|
FIC, NCI, NHLBI, NIAID
|
2015
|
|
Ebola Vaccines Advisory Committee on Immunization Practices (ACIP) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
Effective Data Management Subgroup of the Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council Subcommittee on Open Science (NSTC OSTP SOS-EDM)
|
Committee, Advisory Group, or Work Group
|
ACL, ASPR, CDC
|
OD/ OSP
|
2019
|
|
EHE Operations Leadership Team (OLT)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS
|
NIAID, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
Emerging Tobacco Products Communication Initiative Subject Matter Expert Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
End-stage Renal Disease Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NICHD
|
2003
|
|
Enhancing Scientific Collaboration between US and Colombia
|
Committee, Advisory Group, or Work Group
|
OGA
|
NIAID, FIC
|
2021
|
|
FDA Antimicrobial Drugs Advisory Committee (FDA AMDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2021
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA-NIH Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/ IMOD, OD/ OER, OD/ OSP
|
2010
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Feasibility Study: Maternal Health Care of Pregnant Women in Custody, Expert Panel
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NICHD
|
|
|
Federal Cannabis Partners
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NIDA, NCI
|
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH, ACL
|
NHLBI, NIDDK
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal Health IT Coordinating Council
|
Committee, Advisory Group, or Work Group
|
CMS, ACF, AHRQ, CDC, FDA, HRSA, IHS, OASH, ASA
|
NHGRI, OD/ OSP
|
2004
|
|
Federal HIV Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal HIV Web Council (HIV.gov) (FHWC)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, FDA, HRSA, IHS, SAMHSA, ACF
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NIAID, NIMH, NIDA, OD/ DPCPSI/ OAR
|
2018
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Workgroup on Autism Spectrum Disorders (FIWA)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA, ASPE, ACF, FDA
|
NINDS, NICHD
|
2018
|
|
Federal Interagency Workgroup on Child Abuse and Neglect (FEDIAWG)
|
Committee, Advisory Group, or Work Group
|
ACF
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
1998
|
|
Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, ONC, SAMHSA, OASH, CMS
|
NIBIB, NLM, NCI, NCATS
|
2018
|
|
Federal Interagency Workgroup on Intellectual Disabilities/Developmental Disabilities (ID/DD) Administrative Data (FIW IAD)
|
Committee, Advisory Group, or Work Group
|
ACL, CMS, ASPE, CDC, HRSA, AHRQ, SAMHSA
|
NICHD, NIMH
|
2020
|
|
Federal Interagency Workgroup on Teen Dating Violence
|
Committee, Advisory Group, or Work Group
|
ACF, CDC
|
NICHD
|
2006
|
|
Federal Interagency Working Group on Measuring Sexual Orientation and Gender Identity (FIW SOGI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CMS, SAMHSA
|
NICHD, OD/ DPCPSI/ SGMRO
|
2015
|
|
Federal Interagency Workshop: Nonhuman Primate Resources and Needs for Biomedical Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ DPCPSI/ OAR, OD/ OIR, OD/ ORS, OD/ OSP, CC, NCCIH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIMH, NINDS
|
2021
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
|
|
|
Federal Partners in Bullying Prevention, Intervention, and Recovery
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
2010
|
|
Federal Sudden Unexpected Infant Death/Sudden Infant Death Syndrome (SUID/SIDS) Workgroup
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS
|
NICHD
|
2009
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Work Group on Suicide Prevention
|
Committee, Advisory Group, or Work Group
|
SAMHSA, CDC, IHS, ACF, ACL, AHRQ, HRSA, ASPE
|
NIDA, NIMH, NIAAA
|
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ORWH, NIAAA
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ONR, OD/ DPCPSI/ ORWH
|
2005
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Foundation for the National Institutes of Health (FNIH) PACT (Partnership for Accelerating Cancer Therapies) (FNIH PACT)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2017
|
|
Gabriella Miller Kids First Common Fund Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/ DPCPSI/ ORIP
|
2015
|
|
Gender Policy Council: HHS Women's Health & Rights Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CDC, OGA, OASH
|
NICHD
|
|
|
Global Health Security Agenda (GHSA) Action Package Prevent 3 (APP3), Biosafety and Biosecurity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2014
|
|
Global Initiative for Cancer Registry Development (GICR)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2014
|
|
Global Nutrition Coordination Plan (GNCP)
|
Committee, Advisory Group, or Work Group
|
CDC, OGA, FDA
|
NICHD, NCI
|
2016
|
|
GlycoBiology Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Government-University-Industry Research Roundtable (GUIRR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ IMOD, NCATS
|
|
|
H-CORE
|
Committee, Advisory Group, or Work Group
|
ASPR/BARDA
|
NIAID
|
2022
|
|
Health Information Technology Advisory Committee (HITAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, ONC
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS
|
2014
|
|
Healthy People 2020/2030 Heart Disease and Stroke Federal Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NHLBI, NINDS
|
2010
|
|
Healthy People 2030 - Chronic Kidney Disease Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS, OASH
|
|
1998
|
|
Healthy People 2030 - Heart Disease and Stroke Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS
|
NHLBI, NINDS
|
2000
|
|
Healthy People 2030 - Nutrition and Weight Status Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, Other
|
NIDDK
|
2010
|
|
Healthy People 2030 - Social Determinants Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OASH, SAMHSA, PSC, FDA
|
NIA, NCI, NIAAA, NIMHD
|
2016
|
|
Healthy People 2030 Chronic Pain Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, OASH
|
|
2020
|
|
Healthy People 2030 Disability and Health Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD
|
|
|
Healthy People Initiative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDCD, NIDDK, NIEHS, NIMH, NINDS
|
1979
|
|
HHS Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
HHS Adult Maltreatment Prevention Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
NIA
|
2018
|
|
HHS Agency Priority Goal on Equity Workgroup (FY 2022-2023)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, CDC, CMS, HRSA
|
OD/ OEDI, NICHD, NIMHD
|
2021
|
|
HHS Antiretroviral Treatment Guidelines Panel for Adults and Adolescents with HIV
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC, FDA
|
NIAID
|
1996
|
|
HHS Behavioral Health Coordinating Council (BHCC) Overdose Prevention Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA, OASH, ASPE
|
NIDA, OD/ OSP
|
2009
|
|
HHS Behavioral Health Coordinating Council, Subcommittee on Children and Youth
|
Committee, Advisory Group, or Work Group
|
HRSA, SAMHSA, FDA, OASH, CMS
|
NICHD, NIMH, NIDA
|
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ ORS, OD/ OSP
|
2015
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NIA, NIAID, NICHD, NIDDK, NIMH, NIMHD
|
2008
|
|
HHS DATA Act Compliance
|
Committee, Advisory Group, or Work Group
|
ASFR
|
OD/ OM/ NBS
|
2020
|
|
HHS Data Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
NLM, NIGMS, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ SGMRO
|
1996
|
|
HHS Data Governance Board
|
Committee, Advisory Group, or Work Group
|
OCIIO, ASPE, CDC, ACF, ACL, AHRQ, CMS, FDA, HRSA, IHS, SAMHSA, ASFR, ASPA, ASPR, OIG
|
OD/ OSP
|
2020
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OASH
|
NIDDK
|
1990
|
|
HHS Disability Collaborative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPA, ASPE, ASFR, ASA, ASPR, ACF, CDC, CMS, OASH, OCR, ONC, OIG, OGA, HRSA, SAMHSA, FDA, IHS
|
NIA, NICHD
|
2020
|
|
HHS Ebola Medical Countermeasures Scientific Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, OGA, CDC, FDA
|
|
2018
|
|
HHS Environmental Justice and Natural Disasters Working Group (EJ)
|
Committee, Advisory Group, or Work Group
|
ASPR, OASH, CDC, HRSA
|
NIEHS
|
2012
|
|
HHS Environmental Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
OASH
|
NIEHS, OD/ DPCPSI/ SGMRO
|
2022
|
|
HHS Health Disparities Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
|
|
HHS HIV Bidirectional Meeting Planning Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIMH
|
2018
|
|
HHS LGBT Policies Coordinating Committee (HHS LGBT CC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIMH, OD/ DPCPSI/ SGMRO
|
2011
|
|
HHS Long COVID Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, AHRQ
|
NIDA, NIMH
|
2022
|
|
HHS Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPE, ASFR, CDC, CMS, FDA, HRSA, IHS, ONC, IOS, ATSDR, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH, NHLBI
|
|
|
HHS Noise-Induced Hearing Loss Federal Partner Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2018
|
|
HHS Nutrition Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, NIH, OASH, SAMHSA, OS
|
NHLBI, NCI, OD/ DPCPSI/ ORWH
|
2021
|
|
HHS Office on Womens Health, Section on Pregnancy and Newborn Care
|
Committee, Advisory Group, or Work Group
|
OS, SAMHSA
|
NICHD, NIMH
|
|
|
HHS Panel for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Potential Pandemic Pathogens Care and Oversight Review Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2018
|
|
HHS Privacy Committee
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
|
|
HHS Reproductive Health Care Access Task Force (HHS RATF)
|
Committee, Advisory Group, or Work Group
|
OASH, OCR, ASPE, AHRQ, CDC, HRSA, IHS
|
OD
|
2022
|
|
HHS SARS-CoV-2 Assay Development Task orders
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
HHS Smoking Cessation Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI
|
2021
|
|
HHS Social Determinants of Health Workgroup
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, AHRQ, CDC, HRSA, IHS, OASH, FDA, CMS, SAMHSA
|
NIA, NICHD
|
2019
|
|
HHS Strategic Plan FY 2022-2026: Subcommittee for Objective 3.4
|
Committee, Advisory Group, or Work Group
|
ASFR, CDC, ACF, SAMHSA, HRSA, ACL, ASPE
|
NICHD, NIMH
|
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIAID
|
2017
|
|
HHS Tobacco Control Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, SAMHSA, OS
|
NCI, NIDA
|
2021
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA, OASH, ONC
|
NIDA, OD/ DPCPSI/ OAR, NIAID, NIDDK
|
2009
|
|
HHS-Wide Stigma Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, IHS, SAMHSA
|
|
2019
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
2017
|
|
ICCFASD SBI Working Group for Pregnant and Postpartum People (ISBI-WG) (ISBI)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, CDC, CMS, IHS, HRSA, SAMHSA
|
NIDA
|
2021
|
|
ICCFASD Strategic Planning Working Group (ISP)
|
Committee, Advisory Group, or Work Group
|
ASPE, CDC, CMS, HRSA, SAMHSA
|
NICHD
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2018
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
IEEE Reporting Standards for In Vivo Neural Interface Research Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
ImmuneChip+ Area of Interest (AOI)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID, NCATS
|
2022
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS, ASPE, FDA
|
NCI, NHLBI, NIMHD, OD/ DPCPSI
|
2015
|
|
Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
CC, NCATS, NCI, NEI, NHGRI, NIAAA, NICHD, NLM, NIA
|
2013
|
|
Interagency Adult Literacy Research Group
|
Committee, Advisory Group, or Work Group
|
ACF
|
NICHD
|
2014
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NICHD, NIEHS, NINDS, NIDCD, OD
|
2000
|
|
InterAgency Board (IAB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
2010
|
|
Interagency Cancer Diagnostic Devises Task Force for Near-Patient Use (CD2)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
|
2019
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAID, NINDS
|
2010
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OASH, Other
|
NCI, OD/ DPCPSI/ ODS, NICHD
|
2013
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
1985
|
|
Interagency Committee on the American Community Survey (ACS)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, OS
|
NICHD
|
2005
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, ASPE, ASPR, ATSDR, CDC, CMS, HRSA, IHS, SAMHSA
|
NIMH, NIDA, NICHD
|
1996
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NINDS, NIDDK
|
1985
|
|
Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, IHS, OS, SAMHSA, OASH
|
NIAAA, NIDA
|
2004
|
|
Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA, CDC
|
NCI, OD, NLM
|
2003
|
|
Interagency Elder Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
ACL
|
NIA
|
2016
|
|
Interagency Filovirus Team
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2019
|
|
Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Group on Alzheimers Disease and Related Dementias for implementation of the National Alzheimers Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, AoA, ASPE, ACF, IHS, OASH, SAMHSA
|
NIA
|
2011
|
|
Interagency Group on SARS-CoV-2 Evolution and Vaccine Cadence
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, ASPR, Other
|
CSR, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, FIC
|
2003
|
|
Interagency Morphine Milligram Equivalent (MME) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIDA
|
2022
|
|
Interagency Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, AHRQ, FDA, SAMHSA
|
NINDS
|
2011
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Pediatric Surge Working Group
|
Committee, Advisory Group, or Work Group
|
NIH, CDC, HRSA, ASPR
|
NICHD
|
|
|
Interagency Policy Council on Nutrition (IPC)
|
Committee, Advisory Group, or Work Group
|
FDA, CMS, IOS, OASH, ACL, AHRQ, ASFR, ASPE, ASPR, CDC, HRSA, IHS, NIH, OS, SAMHSA
|
NCI, NHLBI, NICHD, NIDDK
|
2021
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OM/ OB, OD/ OSP
|
2011
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD
|
2018
|
|
Interagency Working Group (IWG) on Communicating Hazard Information and Other Types of Uncertainty, White House Office of Science and Technology Policy (OSTP) Subcommittee on Social and Behavioral Sciences (SBS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ OBSSR, NCI, NIMHD, NINR, NCATS
|
|
|
Interagency Working Group in the Glycosciences
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Interagency working group on Biological Data Sharing (IWGBDS)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIGMS
|
2018
|
|
Interagency Working Group on Harmful Algal Bloom and Hypoxia Research and Control Act (IWG-HABHRCA)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2014
|
|
Interagency Working Group on Scientific Collections of the National Science and Technology Council (IWGSC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, OD
|
2006
|
|
Interdepartmental Health Equity Collaborative (formerly FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR
|
2006
|
|
Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
|
Committee, Advisory Group, or Work Group
|
CMS, SAMHSA
|
|
2018
|
|
Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIDA
|
2019
|
|
International Cancer Screening Network (ICSN)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2006
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NEI, NHGRI, NIAMS, NICHD, NINDS
|
2011
|
|
International TB Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2014
|
|
Interoperability Standards Priorities Task Force of the Health Information Technology (HIT) Standards Committee
|
Committee, Advisory Group, or Work Group
|
ONC
|
|
2016
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIAID, OD/ ORS, OD/ OSP
|
2005
|
|
JDRF/NIH Beta Cell Replacement Workshop
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK, NIAID
|
2021
|
|
Joint Agency Microbiome Working Group (JAM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ ONR, NCI
|
2017
|
|
Joint Agency Nutrition Working Group (JAN)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NCI, OD/ OSP
|
2016
|
|
Joint External Evaluation Working Group (JEEWG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIEHS, NINDS, OD/ ORS, OD/ OSP
|
|
|
Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCCIH, NCI, NHLBI, NIA, NICHD, NINDS, OD/ DPCPSI/ OBSSR, NIDDK
|
1987
|
|
LGBT Healthy People 2030 Working Group (LGBT HP 2030)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, OD/ DPCPSI/ SGMRO
|
2019
|
|
Liquid Biopsy Working Group (LBWG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
|
2021
|
|
Long-Term Impact of Military-Relevant Brain Injury (LIMBIC) Consortium/Chronic Effects of Neurotrauma Consortium (GENC) Government Steering Committee
|
Committee, Advisory Group, or Work Group
|
ACL
|
|
2019
|
|
Lower Limb Prosthetics Research Standards Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CMS, FDA
|
NIDDK, NICHD, OD
|
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCIH, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2003
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS, CMS
|
NIAID
|
2011
|
|
Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NICHD, NIMHD, OD/ DPCPSI/ ORWH
|
2019
|
|
Medical Expenditure Panel Survey (MEPS): Experiences with Cancer Survivorship Supplement (MEPS CSAQ)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
OD/ DPCPSI/ OBSSR
|
2016
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
MyHealthfinder Steering Committee
|
Committee, Advisory Group, or Work Group
|
ODPHP, OASH, AHRQ, CDC, HRSA, FDA, CMS, SAMHSA
|
NCI, NIA
|
2021
|
|
NAPA Federal Subgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, ACL, CDC, CMS, FDA, HRSA, IHS
|
NINDS
|
2014
|
|
NASEM Aging Disability and Independence Forum
|
Committee, Advisory Group, or Work Group
|
ACL
|
|
2014
|
|
NASEM Forum on Drug Discovery, Development, and Translation
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NINDS, NIAID, NCI, NIMH, OD/ OSP, NCATS
|
|
|
NASEM Forum on Neuroscience and Nervous System Disorders
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIMH, NIAAA, NIA, NIEHS, NIDA
|
2006
|
|
NASEM Forum on Traumatic Brain Injury
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD, NIA
|
2022
|
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAAA, NIDA, OD/ DPCPSI/ OBSSR
|
2010
|
|
National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Advisory Committee on Children and Disasters (NAACD)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, ASPR
|
NICHD, NIEHS
|
|
|
National Amyotrophic Lateral Sclerosis Registry (National ALS Registry)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Asthma Education and Prevention Program
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
1989
|
|
National Cancer Control Strategy
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2017
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2008
|
|
National Coalition for Oversight of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Counterintelligence Task Force (NCITF)
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OM
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2018
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Committee, Advisory Group, or Work Group
|
CDC, IHS, FDA
|
NHLBI, NEI, NIA, NICHD, NIDCR, NIDDK, CSR, NIEHS, OD
|
1997
|
|
National HIV/AIDS Strategy Steering Committee (NHAS)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, HRSA, IHS, SAMHSA, CMS, FDA, ACL, AHRQ
|
NIAID, NIDDK, OD/ DPCPSI/ OAR
|
2021
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2002
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIBIB
|
2012
|
|
National PAD Action Plan
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NIA, NIDDK
|
2018
|
|
National Response Team (NRT)
|
Committee, Advisory Group, or Work Group
|
ASPR, ATSDR, CDC
|
NIEHS
|
2003
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
National Sexually Transmitted Infections (STI) Strategic Plan
|
Committee, Advisory Group, or Work Group
|
OASH, ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID
|
2020
|
|
NBS Implementation Plans Joint Capabilities Plans-Clinical Research Capacity, Therapeutics
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NIAID
|
2022
|
|
NCCOR- National collaborative for childhood obesity research
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2019
|
|
NCI Cancer Data Standards Repository and Registry (caDSR)
|
Committee, Advisory Group, or Work Group
|
FDA, ASPE
|
CIT, NEI, NHLBI, NIAMS, NIBIB, NICHD, NIMH, NINDS, NLM, NIDA, NIDCD, NCATS
|
2000
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
|
2007
|
|
NCI Fecal Microbiota Transplants and Defined Microbiota Cancer Therapeutics Clinical Research Working Group/NCI Convenes Workshop on Reproducibility of Fecal Microbiota Transplants in Cancer Therapeutics
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2019
|
|
Networking and Information Technology Research and Development (NITRD) Program
|
Committee, Advisory Group, or Work Group
|
AHRQ, ONC, CDC
|
NLM, NHGRI, NIBIB, NCI, NCATS, NIGMS, OD/ DPCPSI/ ODSS
|
1991
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHGRI, NLM
|
2009
|
|
NHAS Quality of Life Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA, ACL
|
NIMH, NIAID
|
2022
|
|
NIAID/Armed Forces Radiobiology Research Institute (AFRRI) Research Coordination Team (RCT)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2012
|
|
NIAID/CDC Dual Use Research of Concern (DURC) Risk Mitigation Reviews
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2015
|
|
NIAID/NASA Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NHLBI
|
2017
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIDA-FDA Interagency Clinical Outcomes Assessment Working Group (ICOAWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA, NCI, OD/ DPCPSI/ OBSSR
|
|
|
NIEHS SBIR PHASE IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2016
|
|
NIH Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID, OD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIBIB
|
2003
|
|
NIH Common Data Elements Task Force (CDETF)
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, CMS, ASPE, CDC
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODSS, OD/ OER, OD/ AoU, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ SGMRO, OD/ ECHO, NIGMS, NIMH, NIMHD
|
2012
|
|
NIH COVID-19 Treatment Guidelines Panel
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2020
|
|
NIH Medical Rehabilitation Coordinating Committee (MRCC)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIMH, NINDS, NINR
|
1999
|
|
NIH, HUD, CDC Housing and Health Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NICHD, NIDDK, NHLBI, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR
|
2019
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group (ICOAWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ SGMRO
|
2010
|
|
NIH-FDA Medical Device Research Interest Group (MDRIG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIBIB, NICHD, NIDDK, NINR, OD/ DPCPSI/ ORIP, FIC, NIAMS, NIDA, NCCIH, NHGRI, NIAAA, NIDCD, NIGMS, NIEHS, NLM, OD
|
2016
|
|
NIH/BARDA Antimicrobial Resistance (AMR) Diagnostic Challenge Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA, CDC
|
NIAID
|
2015
|
|
NINDS Common Data Elements Program
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CIT, NINDS, NICHD, NEI, NHGRI, NCATS, NIA, NIMH, NIEHS, NIGMS, NIBIB, NIDDK, NIDCR, NINR, NHLBI
|
2006
|
|
NIOSH SGM Equity Work Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2021
|
|
NITRD Digital Health R&D Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, ONC
|
NCATS, NHLBI, NIA, NIMH, NIBIB, NICHD, OD/ DPCPSI/ OBSSR, OD/ OSP
|
2011
|
|
NSTC Subcommittee on Biological Defense Research and Development - Interagency Bioconvergence Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OSP
|
2020
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
|
|
NSTC Subcommittee on Biological Sciences -Interagency Synthetic Biology Working Group (BSSC-SBWG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIBIB, OD/ OSP
|
2019
|
|
NSTC Subcommittee on Open Science (NSTC SOS)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPR, CDC, FDA
|
OD/ DPCPSI/ ODSS
|
2016
|
|
Nutrition Research Coordinating Committee (NRCC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, OASH
|
NCATS, NCCIH, FIC, CSR, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ ECHO
|
1975
|
|
ODP Prevention Scientific Interest Groups (SIGs)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OASH, FDA
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMHD, NINDS
|
2016
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
OD, NIAID, OD/ DPCPSI
|
2007
|
|
Office of National Drug Control Policy (ONDCP) Data Interagency Working Group (DIWG)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIAAA
|
2021
|
|
ONDCP Harm Reduction Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
SAMHSA, ASPE, CMS, HRSA, CDC
|
NIDA
|
2022
|
|
ONDCP Methadone Modernization Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CMS
|
NIDA
|
2022
|
|
One Health Coordination Unit (OHCU)
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
|
|
Open Science Infrastructure Working Group of the Subcommittee on Open Science of the National Science and Technology Council (OSI)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPR, CDC, FDA
|
OD/ DPCPSI/ ODSS, OD/ OSP, OD/ OER
|
2021
|
|
OS-Patient-Centered Outcomes Research Trust Fund (PCORTF) CMS Pilot Data Linkage Projects Discussion
|
Committee, Advisory Group, or Work Group
|
ASPE, CDC, CMS
|
NICHD, NCATS, NIA, NCCIH, NIDDK
|
|
|
PAR 22-049 'Integrating Biospecimen Science Approaches into Clinical Assay Development' Steering Committee Collaboration
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2020
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
|
2015
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
|
|
|
Pediatric COVID-19/MIS-C Interagency Team
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NICHD, NHLBI, NIAID
|
2020
|
|
Pediatric Radiation Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NICHD
|
2022
|
|
Persistent Identifiers subgroup of the Subcommittee on Open Science of the National Science and Technology Council
|
Committee, Advisory Group, or Work Group
|
ACL
|
OD, OD/ DPCPSI/ ODSS
|
2022
|
|
Pilot Biosurveillance Working Group - National Biodefense Strategy
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2021
|
|
Post-Traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI), Suicide Prevention National Research Action Plan (NRAP) Workgroup
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAAA, NIDA, NINDS
|
2012
|
|
PRAMS Interagency Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, NIH, CMS, HRSA
|
NICHD
|
|
|
Precision Oncology Interest Group (POIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID, NHLBI, NIDDK, NIAMS, NCATS, NINDS, NIBIB, NICHD, NIDCR, OD
|
2021
|
|
Pregnancy and Birth to 24 Months Project (P/B-24)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
Pregnant People, Substance Use Disorder and Child Welfare, Sub Interagency Policy Committee (IPC) of the Maternal Health IPC
|
Committee, Advisory Group, or Work Group
|
ACF, ASPE, CDC, HRSA, IHS, SAMHSA, OS, IOS
|
NIDA, NICHD
|
2022
|
|
President's Advisory Council for HIV/AIDS (PACHA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, IHS, OASH
|
OD/ DPCPSI/ OAR
|
2016
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Cervical Cancer Prevention Expert Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2018
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NHLBI, NIMH, NIMHD
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS
|
|
|
President’s Task Force (PTF) on Environmental Health Risks and Safety Risks to Children: Chemical Exposures (ChEx) Subcommittee
|
Committee, Advisory Group, or Work Group
|
FDA, OASH
|
NIEHS
|
1997
|
|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2015
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS, FDA, OASH
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODS, OD/ OLPA
|
1997
|
|
Probiotic and Prebiotic Working Group [PPWG] (PPWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS, CC, CIT, CSR, FIC, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OEDI
|
2006
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group (PHEMCE PACT Working Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Service Technology Transfer Policy Board (TTPB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
OD/ OIR/ OTT, OD/ OSP, OD/ OIR, OD/ OER
|
1994
|
|
Radiation and Chemical Defense Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIEHS, NIAMS
|
2020
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NIAID
|
2003
|
|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
2018
|
|
Reentry Research Network
|
Committee, Advisory Group, or Work Group
|
ACF, SAMHSA
|
NIDA, OD/ DPCPSI/ OBSSR
|
2012
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
2018
|
|
Review Policy Committee (RPC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, NIDCD, OD
|
|
|
Revision of Centers for Disease Control and Prevention (CDC) Guidelines on Hepatitis B
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2011
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NIAID
|
2021
|
|
SARS-CoV-2 evolution in immunocompromised people
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2022
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
|
2021
|
|
SARS-CoV-2Interagency Working Group: Therapeutics, Diagnostics, Vaccines. DCR involved in Thx and DX (SIG)
|
Committee, Advisory Group, or Work Group
|
NIH, FDA, ASPR
|
NIAID
|
2021
|
|
Secretary's Advisory Committee on Infant Mortality
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
1991
|
|
Senior Medical Advisor to Assistant Secretary for Preparedness and Response (ASPR)
|
Committee, Advisory Group, or Work Group
|
OS, IOS
|
|
2004
|
|
SHIELD Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2019
|
|
Sickle Cell Disease Federal Interagency Work Group (SCD FIWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, HRSA, OASH
|
NHLBI
|
2019
|
|
Social Determinants of Health Interagency Policy Committee (SDOH-IPC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, SAMHSA, Other, ASPR
|
|
2021
|
|
Social Determinants of Health Research Coordinating Committee (NIH SDOH RCC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIMHD, NIA, NINR, NIEHS, NCATS, FIC, NIAMS, NCCIH, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODP, OD/ DPCPSI/ OBSSR
|
2022
|
|
Special Populations Research Forum, Clinical Research Recommendations Subcommittee (SPRF-CRRC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NINDS, NHLBI, OD/ DPCPSI/ SGMRO, OD/ AoU
|
2022
|
|
State of Illinois - Governor Challenge
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
|
2020
|
|
Steering Committee of the Scientific Interest Group in Glycobiology
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Subcommittee on Open Science (Formerly Interagency Working Group on Open Science)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPR, CDC, CMS, FDA
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
SUDV Medical Countermeasures Acceleration Meeting
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Synthetic DNA Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2018
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, ASPR
|
NIAID
|
2014
|
|
The Administration for Strategic Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense subject matter expert team
|
Committee, Advisory Group, or Work Group
|
OS, ASPR
|
NIAID
|
2004
|
|
The APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Steering Committee Meetings
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIDDK, NIMH
|
2018
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
OD/ OSP
|
2001
|
|
The President's Task Force on Environmental Health risks and Safety risks to children; Asthma Disparities working group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, IHS
|
NIAID, NICHD, NIMHD, NINR
|
2012
|
|
The Scientific Registry of Transplant Recipients (SRTR) Visiting Committee
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID
|
2011
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, SAMHSA, FDA, CMS
|
FIC, NCI, NEI, NHGRI, CSR, NCCIH, NIAMS, NIMH
|
2003
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Toxins Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
NIAID
|
2019
|
|
Training Advisory Committee (TAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ ORIP
|
|
|
Trans-Agency (Medical) Imaging Phantom (TAIP) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB
|
2021
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2009
|
|
Trans-NIH Liver Cancer Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDDK, NIAAA, NIAID
|
2016
|
|
Trans-NIH Mitochondrial Disorders Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH, NIA, NIGMS, NICHD, NIEHS, NEI, NIDDK, NCATS, NCI, NHLBI, NIAMS
|
|
|
Trans-NIH Working Group for Objective Measures in Cancer
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NIDDK
|
2017
|
|
U.S. and Canada Human Milk Composition Initiative (HMCI)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, OD/ DPCPSI/ ODS, NIDDK, NCI
|
|
|
U.S. Breastfeeding Coalition (USBC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, HRSA, IHS, OASH
|
NICHD
|
|
|
U.S. FDA Medical Imaging Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2015
|
|
U.S. Preventative Services Task Force (USPSTF), NIH IC Liaison Group
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NIA, NIAID, NICHD, NIMHD, NINR, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH
|
1984
|
|
United States Government Children in Adversity Working Group (APCCA WG)
|
Committee, Advisory Group, or Work Group
|
CDC, ACF
|
FIC, NICHD, NIEHS, NIMH
|
2011
|
|
United States Government Global Nutrition Coordination Plan
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2016
|
|
United States Government SARS-CoV-2 Interagency Group (SIG), Genomic Surveillance and Bioinformatics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2021
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAID
|
2015
|
|
USDA-HHS Birth to 24 Months Pregnant Women Project Federal Expert Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR
|
2012
|
|
Vaccines and Related Biological Products Advisory Committee (VRBPAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2018
|
|
Virology Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
1994
|
|
White House Gender Policy Council: Science & Technology Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OASH, FDA
|
NICHD, NCI
|
2021
|
|
Working Groups to Develop HIV/AIDS Treatment and Prevention Guidelines
|
Committee, Advisory Group, or Work Group
|
OASH
|
CC, NIAID, NICHD, NLM, OD/ DPCPSI
|
2005
|
|
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day observances
|
Committee, Advisory Group, or Work Group
|
OGA
|
FIC
|
2017
|
|
World Health Organization (WHO) Programme on Prevention of Deafness and Hearing Loss
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2017
|
|
World Health Organization Pediatric Antiretroviral Drug Optimization (PADO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
Year of Open Science subgroup of the Subcommittee on Open Science of the National Science and Technology Council
|
Committee, Advisory Group, or Work Group
|
CDC
|
|
2022
|
|
|